PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 44.10
0.00 (0.00%)
Oct 2, 2026, 5:30 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.46 billion as of October 2, 2026. Its market cap has increased by 85.43% in one year.
Market Cap
1.46B
Enterprise Value
1.54B
Revenue
423.58M
Ranking
n/a
PE Ratio
107.85
Stock Price
44.10
ChartMarket Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.46B, a decrease of -43.79%. That is a compound annual growth rate of -10.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.46B | 69.09% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 279.40B |
| Novartis AG | 228.01B |
| Lonza Group AG | 39.15B |
| Galderma Group AG | 37.50B |
| Medacta Group | 2.27B |
| SKAN Group AG | 1.59B |
| Aevis Victoria | 1.34B |
| Idorsia | 1.25B |